Why Measles Keeps Coming Back

Measles was, for a period, treated by public health authorities in many high-income countries as a largely solved problem — a disease that persisted in pockets of the world with weaker health infrastructure, but that had been effectively eliminated elsewhere through sustained vaccination programmes. That framing no longer holds. Outbreaks have been reported in numerous countries that had previously achieved or come close to elimination status, and the underlying pattern behind them is consistent: falling childhood vaccination coverage rather than any change in the virus itself.

Why measles is so unforgiving of gaps in coverage

Measles is among the most contagious pathogens known, with a single infected person capable of transmitting it to a large number of susceptible contacts in an unvaccinated population. Because of this, the herd immunity threshold required to reliably prevent sustained outbreaks is unusually high, generally cited at around 95 per cent coverage with two vaccine doses. Coverage that looks reasonably high in national aggregate — in the high eighties or low nineties per cent, for instance — can still leave measles outbreaks entirely possible, particularly where unvaccinated people cluster geographically or socially rather than being evenly distributed.

• The MMR vaccine (measles, mumps and rubella) has an extremely strong safety record, established over decades of use and large-scale post-marketing surveillance.
• Vaccination coverage in numerous countries dipped during the disruption to routine healthcare services around the pandemic years and has not fully recovered in several.
• Coverage gaps are frequently concentrated in specific communities or regions rather than spread evenly, which matters enormously for a disease that relies on sustained chains of transmission.

What's driving the coverage decline

The causes are varied and country-specific, but several recurring factors show up across affected regions: persistent vaccine misinformation circulating on social media, healthcare access disruptions that have not fully reversed since the pandemic, declining trust in some public institutions more broadly, and, in some lower-income settings, straightforward supply and logistics constraints rather than hesitancy per se. Distinguishing between hesitancy-driven gaps and access-driven gaps matters for policy, because the interventions that address one do very little for the other.

Every outbreak we're seeing now is, in effect, a delayed consequence of a vaccination gap that opened months or years earlier. The virus is just doing what it always does when given the opportunity.

Who bears the greatest risk

• Infants too young to have received their first scheduled MMR dose, who rely entirely on population-level immunity for protection.
• Immunocompromised individuals, who often cannot receive live vaccines themselves and depend on herd immunity.
• Measles infection itself can cause a phenomenon called immune amnesia, temporarily weakening the immune system's memory of other pathogens and increasing vulnerability to unrelated infections for months afterward.
• Rare but serious complications, including encephalitis and, years later in a small number of cases, a fatal degenerative brain condition called subacute sclerosing panencephalitis.

What restoring coverage requires

Public health responses that have shown some success in reversing local declines generally combine several elements: targeted outreach in under-vaccinated communities delivered by trusted local figures rather than generic public messaging, addressing practical access barriers such as clinic hours and transport, and school-entry vaccination requirements where politically and legally feasible. None of these is a fast fix, and rebuilding coverage that has eroded over several years typically takes a comparable amount of sustained effort to restore. In the meantime, the pattern of outbreaks in previously low-risk countries is likely to continue wherever coverage gaps persist.